Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis

This systematic review and meta-analysis sought to evaluate the acceptability levels for COVID vaccine(s) in various states in India. Published articles in PubMed/Scopus/Cochrane/DOAJ/the Web of Science that focused on assessing COVID-19 vaccine hesitation/vaccine acceptance using a survey/questionnaire were included. After extensive research, 524 records were found, and after screening on the basis of eligibility criteria, only 23 papers were added to this review. Increased vaccine assumption percentage (>70%) among the population was found in two surveys nationwide (92.8%) and in Delhi (79.5%). For pooled estimates of COVID-19 vaccine acceptance and heterogeneity, twenty-three studies (23) consisting of 39,567 individuals reported for acceptance of COVID 19 vaccine in India.. Out of these, 26,028 individuals accepted the COVID-19 vaccine, giving a pooled estimate of 62.6% (95% CI: 55.6-69.4) with considerable heterogeneity (?(2) = 3397.3, p < 0.0001; I-2 = 99.40%). The results of this study give a brief insight into the percentage acceptance and hesitancy among the Indian population regarding COVID-19 vaccine immunisation. Future research and vaccine education initiatives can be steered by the findings of this work as a starting point.

Automated summary

This systematic review and meta-analysis examined the acceptability levels of COVID vaccines in different states in India. After screening numerous articles, 23 papers were included in the review, which revealed a high acceptance rate (>70%) for the vaccine among the Indian population. The pooled estimate showed that 62.6% of individuals in India accepted the COVID-19 vaccine, indicating considerable heterogeneity in acceptance.